Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Taubert

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 13, 2019
Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarraysMarkus Eckstein, Verena Sailer, Boye Schnack Nielsen, et al.
Cells|November 26, 2022
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer PatientsVerena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
BMC Cancer|February 26, 2010
Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patientsHelge Taubert, Chris Heidenreich, Hans-Jürgen Holzhausen, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
BMC Cancer|March 22, 2014
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective studyAnja Rogler, Sabine Hoja, Johannes Giedl, et al.
Cancers|December 28, 2019
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier GenesSven Wach, Helge Taubert, Katrin Weigelt, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
Scientific Reports|November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behaviorAdrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Nature Reviews. Urology|November 30, 2022
Experimental in vitro, ex vivo and in vivo models in prostate cancer researchVerena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Urologic Oncology|July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancerDanijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 13, 2019
Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarraysMarkus Eckstein, Verena Sailer, Boye Schnack Nielsen, et al.
Cells|November 26, 2022
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer PatientsVerena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
BMC Cancer|February 26, 2010
Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patientsHelge Taubert, Chris Heidenreich, Hans-Jürgen Holzhausen, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
BMC Cancer|March 22, 2014
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective studyAnja Rogler, Sabine Hoja, Johannes Giedl, et al.
Cancers|December 28, 2019
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier GenesSven Wach, Helge Taubert, Katrin Weigelt, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
Scientific Reports|November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behaviorAdrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Nature Reviews. Urology|November 30, 2022
Experimental in vitro, ex vivo and in vivo models in prostate cancer researchVerena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Urologic Oncology|July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancerDanijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Pageof 17